For Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition
By Linda E. Mccuistion Phd
Questions And Answers Graded A+
,Table Of Contents
Chapter 01: Drug Development And Ethical Considerations .................................................................4
Chapter 02: Pharmacokinetics, Pharmacodynamics, Andpharmacogenetics .................................... 11
Chapter 03: Cultural Considerations ................................................................................................ 18
Chapter 04: Complementary And Alternative Therapies .................................................................... 21
Chapter 05: Pediatric Considerations. ............................................................................................. 26
Chapter 06: Geriatric Considerations ............................................................................................... 31
Chapter 07: Drugs In Substance Use Disorder...................................................................................36
Chapter 08: The Nursing Process And Patient-Centered Care ............................................................ 45
Chapter 09: Safety And Quality ........................................................................................................ 49
Chapter 10: Drug Administration ...................................................................................................... 54
Chapter 11: Drug Calculations ......................................................................................................... 58
Chapter 12: Fluid Volume And Electrolytes ....................................................................................... 63
Chapter 13: Vitamin And Mineral Replacement.................................................................................. 70
Chapter 14: Nutritional Support ....................................................................................................... 76
Chapter 15: Adrenergic Agonists And Antagonists ............................................................................83
Chapter 16: Cholinergic Agonists And Antagonists ........................................................................... 89
Chapter 17: Stimulants .................................................................................................................... 94
Chapter 18: Depressants ................................................................................................................ 98
Chapter 19: Antiseizure Drugs ........................................................................................................103
Chapter 20: Drugs For Parkinsonism And Alzheimer's Disease ....................................................... 109
Chapter 21: Drugs For Neuromuscular Disorders And Musclespasms ............................................. 114
Chapter 22: Antipsychotics And Anxiolytics ................................................................................... 120
,Chapter 23: Antidepressants And Mood Stabilizers ....................................................................... 126
Chapter 24: Antiinflammatories ..................................................................................................... 132
Chapter 25: Analgesics ................................................................................................................. 144
Chapter 26: Antibacterials ..............................................................................................................150
Chapter 27: Antituberculars, Antifungals, And Antivirals ..................................................................159
Chapter 28: Peptides, Antimalarials, And Anthelmintics .................................................................. 165
Chapter 29: Hiv- And Aids-Related Drugs ........................................................................................ 175
Chapter 30: Transplant Drugs ......................................................................................................... 179
Chapter 31: Vaccines .................................................................................................................... 182
Chapter 32: Anticancer Drugs ....................................................................................................... 186
Chapter 33: Targeted Therapies To Treat Cancer............................................................................... 190
Chapter 34: Biologic Response Modifiers ........................................................................................ 192
Chapter 35: Upper Respiratory Disorders ....................................................................................... 196
Chapter 36: Lower Respiratory Disorders ........................................................................................ 200
Chapter 37: Cardiac Glycosides, Antianginals, Andantidysrhythmics ............................................... 204
Chapter 38: Diuretics .....................................................................................................................211
Chapter 39: Antihypertensives ...................................................................................................... 214
Chapter 40: Anticoagulants, Antiplatelets, And Thrombolytics.......................................................... 220
Chapter 41: Antihyperlipidemics And Peripheral Vasodilators ........................................................ 225
Chapter 42: Gastrointestinal Tract Disorders .................................................................................. 229
Chapter 43: Antiulcer Drugs .......................................................................................................... 240
Chapter 44: Eye And Ear Disorders................................................................................................. 245
Chapter 45: Dermatologic Disorders .............................................................................................. 248
Chapter 46: Pituitary, Thyroid, Parathyroid, And Adrenaldisorders ................................................... 252
Chapter 47: Antidiabetics .............................................................................................................. 258
Chapter 48: Urinary Disorders ........................................................................................................264
Chapter 49: Pregnancy And Preterm Labor ..................................................................................... 268
Chapter 50: Labor, Delivery, And Postpartum .................................................................................. 273
Chapter 51: Neonatal And Newborn ............................................................................................... 276
, Chapter 52: Women's Reproductive Health .....................................................................................280
Chapter 53: Men's Reproductive Health ......................................................................................... 283
Chapter 54: Sexually Transmitted Infections ................................................................................... 286
Chapter 55: Adult And Pediatric Emergency Drugs. ........................................................................290
Chapter 01: Drug Development And Ethical Considerations
Multiple Choice